celecoxib and adenosine diphosphate

celecoxib has been researched along with adenosine diphosphate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Adler, R; Eskra, J; Noveck, R; Rushing, M; Vargas, R; Walden, C; Wilner, KD	1
Capone, ML; D'Amelio, E; De Caterina, R; Grana, M; Patrignani, P; Patrono, C; Price, TS; Renda, G; Sacchetta, D; Santarelli, F; Sciulli, MG; Tacconelli, S; Zimarino, M; Zurro, M	1
Singh, C; Yadav, A	1

Trials

2 trial(s) available for celecoxib and adenosine diphosphate

Article	Year
Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. Journal of clinical pharmacology, 2002, Volume: 42, Issue:9 Topics: Adenosine Diphosphate; Adolescent; Adult; Arachidonic Acid; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thromboxane B2	2002
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:3 Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Celecoxib; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Ibuprofen; Male; Middle Aged; Myocardial Ischemia; Osteoarthritis; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrazoles; Sulfonamides; Thromboxane B2; Treatment Outcome	2006

Article

Year

Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers.

Journal of clinical pharmacology, 2002, Volume: 42, Issue:9

Topics: Adenosine Diphosphate; Adolescent; Adult; Arachidonic Acid; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thromboxane B2

2002

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.

Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:3

Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Celecoxib; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Ibuprofen; Male; Middle Aged; Myocardial Ischemia; Osteoarthritis; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrazoles; Sulfonamides; Thromboxane B2; Treatment Outcome

2006

Other Studies

1 other study(ies) available for celecoxib and adenosine diphosphate

Article	Year
Cyclooxygenase-2 activates the free radical-mediated apoptosis of polymorphonuclear leukocytes in the maneb- and paraquat-intoxicated rats. Pesticide biochemistry and physiology, 2022, Volume: 187 Topics: Adenosine Diphosphate; Animals; Apoptosis; Caspase 3; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochromes c; Free Radicals; Humans; JNK Mitogen-Activated Protein Kinases; Lipid Peroxides; Maneb; Neutrophils; NF-kappa B; Oxidative Stress; Paraquat; Pesticides; Rats; Ribose; Superoxide Dismutase	2022

Article

Year

Cyclooxygenase-2 activates the free radical-mediated apoptosis of polymorphonuclear leukocytes in the maneb- and paraquat-intoxicated rats.

Pesticide biochemistry and physiology, 2022, Volume: 187

Topics: Adenosine Diphosphate; Animals; Apoptosis; Caspase 3; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochromes c; Free Radicals; Humans; JNK Mitogen-Activated Protein Kinases; Lipid Peroxides; Maneb; Neutrophils; NF-kappa B; Oxidative Stress; Paraquat; Pesticides; Rats; Ribose; Superoxide Dismutase

2022